Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease (Q73532895)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11215556%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11215556%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

S Verma

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11215556%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

B Kirkwood

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11215556%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Brown

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11215556%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M H Giaffer

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11215556%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11215556%20AND%20SRC:MED&resulttype=core&format=json

Digestive and Liver Disease

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11215556%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11215556%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11215556%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

769-774

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11215556%20AND%20SRC:MED&resulttype=core&format=json

Elemental diet as primary treatment of acute Crohn's disease: a controlled trial

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Comparison of amino acid v peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Corticosteroid or corticotrophin therapy in Crohn's disease (regional enteritis).

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Long-term effects of elemental and exclusion diets for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Remission induced by an elemental diet in small bowel Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Controlled trial of supplemented oral nutrition in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Chronic intermittent elemental diet improves growth failure in children with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Use of elemental diets in the treatment of Crohn's disease by gastroenterologists

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Frequency of glucocorticoid resistance and dependency in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

Steroid dependency in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980353-9

7 January 2021

10.1016/S1590-8658(00)80353-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11215556%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference